Analyst: Bose hearing aid exit reflects market complexity

If Bose believed it could achieve great success on the hearing aid market, the firm wouldn’t be dropping its business making said devices, says Sydbank analyst Søren Løntoft Hansen.
Søren Løntoft Hansen, senior equity analyst at Sydbank | Photo: sydbank / pr
Søren Løntoft Hansen, senior equity analyst at Sydbank | Photo: sydbank / pr
by marketwire, translated by daniel pedersen

US-based Bose is apparently pulling the plug on its health division, under which the audio firm had been working on a hearing aid targeting the upcoming over-the-counter (OTC) sales channel in the US, news media The Boston Globe writes.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading